Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants.
Kobayashi M, Nakahara K, Seki T, Miki S, Kawauchi S, Suyama A, Wakasa-Morimoto C, Kodama M, Endoh T, Oosugi E, Matsushita Y, Murai H, Fujishita T, Yoshinaga T, Garvey E, Foster S, Underwood M, Johns B, Sato A, Fujiwara T. Kobayashi M, et al. Among authors: fujishita t. Antiviral Res. 2008 Nov;80(2):213-22. doi: 10.1016/j.antiviral.2008.06.012. Epub 2008 Jul 14. Antiviral Res. 2008. PMID: 18625269
Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics.
Nakahara K, Wakasa-Morimoto C, Kobayashi M, Miki S, Noshi T, Seki T, Kanamori-Koyama M, Kawauchi S, Suyama A, Fujishita T, Yoshinaga T, Garvey EP, Johns BA, Foster SA, Underwood MR, Sato A, Fujiwara T. Nakahara K, et al. Among authors: fujishita t. Antiviral Res. 2009 Feb;81(2):141-6. doi: 10.1016/j.antiviral.2008.10.007. Epub 2008 Nov 21. Antiviral Res. 2009. PMID: 19027039
TGF-β signaling promotes desmoid tumor formation via CSRP2 upregulation.
Li Y, Fujishita T, Mishiro-Sato E, Kojima Y, Niu Y, Taketo MM, Urano Y, Sakai T, Enomoto A, Nishida Y, Aoki M. Li Y, et al. Among authors: fujishita t. Cancer Sci. 2024 Feb;115(2):401-411. doi: 10.1111/cas.16037. Epub 2023 Dec 1. Cancer Sci. 2024. PMID: 38041233 Free PMC article.
Decreased liver B vitamin-related enzymes as a metabolic hallmark of cancer cachexia.
Kojima Y, Mishiro-Sato E, Fujishita T, Satoh K, Kajino-Sakamoto R, Oze I, Nozawa K, Narita Y, Ogata T, Matsuo K, Muro K, Taketo MM, Soga T, Aoki M. Kojima Y, et al. Among authors: fujishita t. Nat Commun. 2023 Oct 6;14(1):6246. doi: 10.1038/s41467-023-41952-w. Nat Commun. 2023. PMID: 37803016 Free PMC article.
Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation.
Takamori S, Seto T, Yamaguchi M, Kinoshita F, Fujishita T, Ito K, Toyozawa R, Shoji F, Okamoto T. Takamori S, et al. Among authors: fujishita t. Front Oncol. 2022 Oct 13;12:965741. doi: 10.3389/fonc.2022.965741. eCollection 2022. Front Oncol. 2022. PMID: 36313664 Free PMC article.
Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: protocol for a multicentre, prospective, observational study.
Shoji F, Yamashita T, Kinoshita F, Takamori S, Fujishita T, Toyozawa R, Ito K, Yamazaki K, Nakashima N, Okamoto T. Shoji F, et al. Among authors: fujishita t. BMJ Open. 2022 Jun 8;12(6):e061674. doi: 10.1136/bmjopen-2022-061674. BMJ Open. 2022. PMID: 35676015 Free PMC article.
91 results